» Articles » PMID: 35773081

First Report of Thoracic Carcinoma With DEK::AFF2 Rearrangement: A Case Report

Overview
Journal J Thorac Oncol
Publisher Elsevier
Date 2022 Jun 30
PMID 35773081
Authors
Affiliations
Soon will be listed here.
Abstract

DEK::AFF2 carcinomas of the head and neck region have been recently described and reported to have aggressive clinical behavior but exceptional sensitivity to immunotherapy. We report a case of a 26-year-old female, never smoker, with a 5.2-cm left lower lobe central lung mass, with morphologic features identical to those reported for DEK::AFF2 head and neck carcinomas, including mixed papillary exophytic and invasive components, squamous/basaloid features, and monomorphic cytomorphology. DEK (exon 7)::AFF2 (exon 9) fusion was identified by whole-transcriptome RNA sequencing. This is the first report of thoracic DEK::AFF2 carcinoma, indicating that these tumors are not confined to the head and neck region but can involve both upper and lower respiratory tracts. This entity should be considered in the differential diagnosis of squamous cell carcinomas in never smokers lacking other known oncogenic mutations.

Citing Articles

TTF-1 and p40 co-expressing non-small cell lung cancer with ERBB2 and TP53 gene mutations: A case report and review of the literature.

Sun J, Shi H, Sun B, Wei T, Su J, Liu H Medicine (Baltimore). 2025; 104(6):e41290.

PMID: 39928773 PMC: 11813057. DOI: 10.1097/MD.0000000000041290.


Identification of a novel TOP2B::AFF2 fusion gene in B-cell acute lymphoblastic leukemia.

Liu T, Wang Y, An X, Liu J, Wu Y, Xiang Y Sci Rep. 2025; 15(1):3280.

PMID: 39863655 PMC: 11763246. DOI: 10.1038/s41598-025-86865-4.


DEK::AFF2 fusion-associated middle ear non-keratinizing squamous cell carcinoma: A case report.

Sun Y, Zhou Y, Liu X, Shen D World J Clin Oncol. 2024; 15(12):1501-1506.

PMID: 39720645 PMC: 11514374. DOI: 10.5306/wjco.v15.i12.1501.


DEK::AFF2 Fusion-Associated Squamous Cell Carcinoma: A Case Series with Literature Review on an Emerging and Challenging Entity.

Amin S, Lewis Jr J, Bridge J, Hang J, Naik U, Bishop J Head Neck Pathol. 2024; 18(1):86.

PMID: 39312022 PMC: 11420419. DOI: 10.1007/s12105-024-01690-x.


Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature.

Marando A, Zagni M, Negrelli M, Valtorta E, Lauricella C, Motta V Pathologica. 2024; 116(1):13-21.

PMID: 38482671 PMC: 10938280. DOI: 10.32074/1591-951X-957.


References
1.
Yang W, Lee K, Srivastava R, Kuo F, Krishna C, Chowell D . Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat Med. 2019; 25(5):767-775. PMC: 6558662. DOI: 10.1038/s41591-019-0434-2. View

2.
Bishop J, Gagan J, Paterson C, McLellan D, Sandison A . Nonkeratinizing Squamous Cell Carcinoma of the Sinonasal Tract With DEK-AFF2: Further Solidifying an Emerging Entity. Am J Surg Pathol. 2020; 45(5):718-720. DOI: 10.1097/PAS.0000000000001596. View

3.
Pelosi G, Bulloni M, Vescio M, Uccella S, Forest F, Leone G . Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations. JTO Clin Res Rep. 2021; 2(11):100222. PMC: 8551500. DOI: 10.1016/j.jtocrr.2021.100222. View

4.
Sholl L, Nishino M, Pokharel S, Mino-Kenudson M, French C, Janne P . Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations. J Thorac Oncol. 2015; 10(6):951-9. PMC: 4443847. DOI: 10.1097/JTO.0000000000000545. View

5.
Kuo Y, Lewis Jr J, Truong T, Yeh Y, Chernock R, Zhai C . Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tract. Mod Pathol. 2022; 35(11):1587-1595. DOI: 10.1038/s41379-022-01117-4. View